Eurogentec Biologics offers a comprehensive gene to injectable service in the field of biopharmaceutical API development and manufacturing that includes cell line development, process development/optimization, GMP cell banking and GMP Drug Substance/API manufacturing. We have been manufacturing GMP biologics since 1994 and to date have produced over 100 different biopharmaceuticals and released over 500 GMP batches.
We manufacture GMP plasmid DNA API for use as starting material for the production of viral vectors or for use as therapeutic non-viral plasmid DNA mediated gene therapy. All material is produced in accordance FDA 21 CFR Part 210 & 211, EU 2003/94/EC, Eudralex Vol 4, and relevant ICH; the regulatory requirements for sterile injectable products intended for human clinical trials and commercialization.
Request a quote
See our press release Eurogentec Completes Manufacture of 150 g of GMP Plasmid DNA for Major Pharmaceutical Company.